Search CoinDesk
Price
Indices
CoinDesk 20 Index
Bitcoin Offerings
Ethereum Offerings
Trend Indicators
Indices
Crypto Sectors
Election 2024
News
Markets
Finance
Policy
Tech
Learn
Opinion
Consensus Magazine
Video
Podcasts
CoinDesk Podcast Network
Markets Daily
Generation C
The Protocol
Unchained with Laura Shin
The Mining Pod
Newsletters
The Node
First Mover
State of Crypto
Crypto Long & Short
The Protocol
Crypto for Advisors
Sponsored
Thought Leadership
Press Release
Advertise
Consensus
Consensus 2024 in Austin
Consensus 2025 in Hong Kong
Webinars
Prices
Indices
Consensus
Sponsored
Election 2024
BTC
$67,728.70
+1.98%
ETH
$3,252.27
+2.12%
BNB
$579.56
+1.16%
SOL
$181.93
+4.72%
XRP
$0.59762730
-0.68%
DOGE
$0.13333021
+4.82%
CD20
$2,285.89
+2.77%
TON
$6.67
+0.67%
ADA
$0.41420924
+3.87%
TRX
$0.13761926
+1.04%
AVAX
$28.61
+4.74%
WBTC
$67,829.93
+2.16%
Ad
Amgen
Markets
Us
Big Pharma Seeks DLT Solution for Drug Costs
Pharma heavyweights open up about how they envision a blockchain system improving the research and development process of new drugs.
By
Aaron Stanley
Sponsored
Jan 9, 2018 at 5:04 a.m. UTC
Jan 9, 2018
US
Healthcare
Pharmaceuticals
Pfizer
Amgen
Sanofi
Features
use-cases-verticals
business news
us-canada